Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stayhard and Round Two founder, Luke Fracher, in a unique design collaboration

Swedish online menswear store Stayhard is launching a collection in collaboration with fashion entrepreneur and sneaker specialist Luke "Mook" Fracher. Luke is, together with Sean Wotherspoon and Chris Russow, the founders of the esteemed streetwear resale stores Round Two, which has become a world phenomenon for a new generation buy-sell-trade consumers. The collection that will bring the Round Two hype to Sweden will release this May.The collaboration consists of a 17 piece strong collection that embodies Luke’s discerned fashion sense and personal sartorial point of view. Grails from his

First patient treated with C-RAD’s cutting-edge positioning system at the Cancer Care Center Negrar-Verona, Italy

C-RAD and Ospedale Sacro Cuore Don Calabria – the Cancer Care Center in Negrar-Verona - announced today that the first patient has been treated with C-RAD’s surface tracking system at the site. In Italy, the installation is with four C-RAD systems the largest single hospital installation and the first installation on Varian linear accelerators. Ospedale Sacro Cuore Don Calabria is a Research Institute (IRCCS) and the Cancer Care Center in Negrar-Verona. The installation of three Catalyst HD™ systems and one Sentinel 4DCT™ was completed beginning of April. The first patient treated was

Pharmacolog is expanding its product portfolio

Pharmacolog introduces two new product concepts based on its patented DrugLog® technology. WasteLog™ and PrepLog™ are newly developed solutions to specifically address the market for Drug Diversion and the market for drug controls in an integrated environment. The products are currently being developed but are expected to be fully launched in the latter part of 2019.Pharmacolog is engaged in the development and testing of two new product concepts, WasteLog™ and PrepLog™, both of which are based on the technology available in the current DrugLog® but with newly developed software. WasteLog™

Nordic Waterproofing updates its long-term financial targets as a result of the adoption of IFRS 16 and discontinued disclosure of items affecting comparability

The Board of Directors of Nordic Waterproofing Holding A/S (STO: NWG.ST) has updated the Group’s long-term financial targets following the adoption of the IFRS 16 Leases standard. In addition, the Board of Directors has decided to discontinue the disclosure of items affecting comparability.As a result of the adoption of IFRS 16 Leases standard as of January 1, 2019, and the discontinued disclosure of items affecting comparability, many key figures have been affected, e.g. EBITDA increased, ROCE-% decreased and net debt and net debt to EBITDA increased. Nordic Waterproofing therefore

Ex dividend NOK 3.25 today

The shares in Atea ASA will be traded ex dividend NOK 3.25  as from today, 02.05.2019. For further information, please contact:Steinar Sønsteby, CEO Atea ASA, mobile (+47) 930 55 655Robert Giori, CFO Atea ASA, mobile (+47) 934 09 188 About Atea Atea is the leading supplier of IT infrastructure and system integration in the Nordic and Baltic regions with more than 7,300 employees. Atea is present in 87 cities in Norway, Sweden, Denmark, Finland, Lithuania, Latvia and Estonia. Atea delivers IT products from leading vendors and assists its customers with specialist competencies

BONESUPPORT HOLDING AB (publ) – Published Q1 2019 Interim report

Lund, Sweden, 08.00 am CET, 2 May 2019 – BONESUPPORT™, listed on Nasdaq Stockholm - BONESUPPORT HOLDING AB (publ) - listed on Nasdaq Stockholm - an emerging leader in orthobiologics for the management of bone voids, today publish the financial report for thean emerging leader in orthobiologics for the management of bone voids, today published the interim report for the first quarter 2019. STRONG GROWTH FOR CERAMENT G AND CERAMENT V “The strategic changes initiated in 2018 begin to show results. Our antibiotic-eluting products grew by 54 percent in the quarter and we see a significant

The world’s largest communication network is moving to Hammarby Sjöstad, and Fabege

Publicis Media is a global communications network that is part of the Publicis Group, the world’s largest media and communications network. It is now signing an agreement with Fabege regarding a new office in Luma. The agreement has a duration of 6 years and relates to 2,900 square metres of office space with an annual rent of SEK 10.7m.Publicis Groupe is a French corporate group with over 80,000 employees and operations in over 100 countries. The group is now concentrating its Swedish operations, with more than 200 employees, in Hammarby Sjöstad, which involves co-locating companies such

Q1 report January – March 2019

Highlights first quarter 2019Net collections increased by 77% to EUR 18.9M (Q1 2018 EUR 10.7M)** Cash EBITDA increased by 95% and amounted to EUR 16.8M (Q1 2018: EUR 8.6M) Net profit for the period of EUR 0.0M (Q1 2018: EUR 1.0M) Gross ERC at the end of March 2019 was EUR 217M (Q4 2018: EUR 240M)*** Cash on hand available for investment at the end of March 2019 was EUR 63M (Q4 2018: EUR 60M) Secured super senior RCF of EUR 27M significantly lowering the cost of funding, priced at Euribor plus a margin of 350 basis points and available for period of up to two years Sale

CELLINK launches new tissue model kits

The new tissue model kits were developed to provide customers with tissue-specific bioinks and antibodies. The kits include antibodies from Atlas Antibodies, a collaborator with extensive experience in antibody development and production. CELLINK, the world’s first bioink company and a global leader in bioprinter systems and bioinks, continues innovating new ways to strengthen its position in the field.   Today, CELLINK is announcing the launch of two new tissue model kits — CELLINK SKIN Kit and CELLINK LIVER Kit. These kits give users valuable information about the phenotype of their

Q1 report January – March 2019

Highlights first quarter 2019 Net collections increased by 72% to EUR 18.1M (Q1 2018 EUR 10.5M)** Cash EBITDA increased by 85% and amounted to EUR 16.4M (Q1 2018: EUR 8.9M) Net loss for the period of EUR 0.5M (Q1 2018: profit of EUR 0.9M) Cash on hand available for investment at the end of March 2019 was EUR 61M (Q4 2018: EUR 57M) Secured super senior revolving credit facility of EUR 27M significantly lowering the cost of funding, priced at Euribor plus a margin of 350 basis points and available for a period of up to two years Sale of portfolios in Russia resulted in EUR

SEMCON BECOMES A GLOBAL PARTNER FOR AGCO

Semcon has initiated a multi-year partnership with leading agricultural equipment manufacturer, AGCO. The agreement means that Semcon will be responsible for the development and production of AGCO’s aftermarket information.“We are very happy to be developing our cooperation with AGCO. The goal is to improve the user experience for both machine dealers and customers. The right information at the right time can be crucial for operators to understand how a product works or, for instance, how it can be maintained and repaired effectively, in order to achieve maximum operating time,” says Johan

Wallenstam Interim Report Jan 1–Mar 31, 2019: Strong start to the business plan

Hans Wallenstam, CEO, and Susann Linde, CFO and Head of Investor Relations, comment on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CET) at the latest.A conference call with Susann Linde will take place at 09.30 (CET) at www.financialhearings.com. The presentation is available at www.wallenstam.se/filmsandpresentations. JANUARY 1–MARCH 31, 2019 · Net asset value per share amounted to SEK 83.60 (75.80), which meant an increase of SEK 1.30 per share in the quarter and SEK 4.40 per share to date during the business plan, where the goal is

Hansa Biopharma Announces Upcoming Presentations at the 2019 American Transplant Congress

Lund, Sweden, May 2, 2019 - Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that IDEFIRIX (imlifidase), the Company’s novel IgG-degrading enzyme, will be highlighted in three presentations at the upcoming 2019 American Transplant Congress (ATC), which will be held from June 1 – 5, 2019 in Boston, Massachusetts, USA.In a plenary session on June 5, 2019 at 8:30AM ET, Stanley C. Jordan, M.D., Director of Kidney Transplantation and Transplant Immunology at the Kidney and Pancreas Transplant Center at

Interim Report Q1 2019

Continued strong performance from the US business Q1 2019 highlights · Total net revenues of SEK 174.3 million (139.7), up 24.8 percent · Zubsolv® US net revenues of SEK 161.7 million (131.1), up 23.3 percent in SEK and 9.3 percent in local currency · EBITDA of SEK 12.0 million (-16.6), EBITDA excluding IP litigation costs of SEK 60.8 million (-8.5) · US EBIT of SEK 71.9 million (25.3) · Cash flow from operating activities of SEK 50.9 million (106.3), building a cash balance of SEK 647.4 million (437.5) · Net earnings of SEK 14.1 million (-25.9) · Positive results

LeoVegas AB: First quarter 2019, 1 January– 31 march 2019

“LeoVegas has had a good start to the year – customer loyalty and the inflow of new customers has never been better!”– Gustaf Hagman, Group CEO First quarter 2019: 1 January– 31 march 2019[1]  ·  Revenue increased by 12% to EUR 86.3 m (77.4). ·  Organic growth in local currencies was 4%. ·  Organic growth in local currencies excluding the UK was 19%. ·  EBITDA was EUR 7.2 m (9.5), corresponding to an EBITDA margin of 8.3% (12.3%). ·  Net Gaming Revenue (NGR) from regulated markets was 50% (35%) of total NGR. ·  The number of

INTERIM REPORT, January–March 2019

First quarter in line with expectations considering Veg Tech seasonalityFirst quarter of 2019 · Consolidated net sales increased by 20 percent to SEK 569 m (474), of which organic growth amounted to 5 percent. Acquisitions contributed by 11 percent and currency by 4 percent · Net sales in Product & Solutions amounted to SEK 445 m (368) and in Installation Services to SEK 138 m (119) · EBITDA increased to SEK 18 m (17) · Operating profit (EBIT) decreased to SEK -7 m (2) · ROCE was 12.0 percent (14.0) · Operating cash flow amounted to SEK -49 m (-65) · Earnings per

Sveaskog Becomes Part Owner of SunCarbon AB - Plans for Renewable Lignin Oil Plant

Sveaskog becomes part owner of SunCarbon AB, which developed a technology for producing lignin oil from the pulp mill's black liquor. Lignin is a renewable residual product from cellulose production at pulp mills that can replace products based on fossil raw materials. Sveaskog is Sweden's largest forest owner and is owned by the Swedish state and thus has a responsibility to be a pioneer and an example in sustainable business and in the development of innovations based on the Swedish forest. With this ambition, Sveaskog has since 2014 cooperated with SunCarbon AB and now acquires

Neste Corporation - Managers' Transactions, Vanacker (acquisition)

Neste Corporation, Managers' Transactions, 2 May 2019 at 9 am. (EET)____________________________________________ Person subject to the notification requirementName: Vanacker, PeterPosition: Chief Executive OfficerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14 Notification type: INITIAL NOTIFICATIONReference number: 5493009GY1X8GQ66AM14_20190501111049_4____________________________________________ Transaction date: 2019-04-30Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009013296Nature of the transaction: ACQUISITION Transaction details(1):

Valmet continues to strengthen its stable business by acquiring J&L Fiber Services Inc. in the U.S.

Valmet Oyj's press release on May 2, 2019 at 9:00 a.m. EET Valmet has on May 1, 2019 completed the acquisition of J&L Fiber Services Inc., a manufacturer and provider of refiner segments to the pulp, paper and fiberboard industry. The company is located in Wisconsin, U.S. The enterprise value of the acquisition is approximately EUR 51 million on a cash and debt free basis subject to ordinary post-closing adjustments. J&L Fiber Services manufactures and supplies low-consistency refiner segments that are important wear parts used in pulp and paper production, complementing Valmet's

DDM closes phase 1 of acquisition in Croatia

DDM Holding AG (First North: DDM) announces that the group has closed phase 1 of an acquisition from HETA Asset Resolution of a distressed asset portfolio containing secured corporate receivables in Croatia. The acquisition is made through a Joint Venture structure together with B2Holding where each party holds 50%. The Gross Collection Value (face value) of the total portfolio amounts to approximately EUR 800 million. The acquisition is expected to fully close during Q2 and will be financed by cash on hand and internally generated cash flows. Henrik Wennerholm, CEO of DDM, comments: “

DDM Debt closes phase 1 of acquisition in Croatia

DDM Debt AB (Nasdaq Stockholm: DDM2) announces that the group has closed phase 1 of an acquisition from HETA Asset Resolution of a distressed asset portfolio containing secured corporate receivables in Croatia. The acquisition is made through a Joint Venture structure together with B2Holding where each party holds 50%. The Gross Collection Value (face value) of the total portfolio amounts to approximately EUR 800 million. The acquisition is expected to fully close during Q2 and will be financed by cash on hand and internally generated cash flows. Henrik Wennerholm, CEO of DDM,

Invitation: Presentation of Ambea’s first quarter 2019 results

Hosts: Fredrik Gren, CEO, Daniel Warnholtz, deputy CEO and CFO, and Jacob Persson, Head of Investor Relations.On May 8th at 07:00 (CET) Ambea will publish its first quarter 2019 results. In connection to the announcement, Ambea will host a telephone conference at 10:00 (CET) on Wednesday, May 8th. The presentation will be held in English and also available as webcast on www.ambea.com or direct link: https://edge.media-server.com/m6/p/9uiyo9m8  To ensure that you are connected to the conference call, please dial in at least five minutes before the start of the conference call to

There are no items matching the current filter
There are no more items matching the current filter
Back to top